XC
XDemics Corp
SEC filingBiotechnology · San Rafael, CA
Amount raised$7.4Msold at filing
Total offering$7.4M
Investors in the raise1count reported to the SEC
FiledFeb 6, 2026first sale Oct 21, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Nicole BergmanDirector
Colin CookDirector
Christopher ThanosExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.